Purchase Articles
Showing 97–112 of 157 resultsSorted by latest
-
Medical Resources in Canada and OECD countries. 2019 Edition.000
Read Article -
Close the Gaps: Patient Benefits and Taxpayer Costs of 3 Pharmacare Options
Read Article -
Evidence that innovative medicines improve health and economic outcomes: focused literature review.
Read Article -
Pan-Canadian Pharmaceutical Alliance negotiations 2014-2018
Read Article -
Out-of-pocket prescription drug costs: What are the implications for National Pharmacare?
Read Article -
Taxpayer Cost of National Pharmacare: Disputing the Parliamentary Budget Officer’s Estimate
Read Article -
Coverage of new medicines in Federal-Provincial public drug plans in Canada 2008-2017
Read Article -
Coverage of new medicines in public versus private drug plans in Canada 2008-2017
Read Article -
New Patented Medicine Regulations in Canada: Case Study of a Manufacturer’s Decision-Making
Read Article -
Prescription drug plan coverage 2016: how many Canadians were insured, under-insured or uninsured?
Read Article -
Comparing expert representation on HTA advisory committees in Canada, the UK and Australia
Read Article -
Facts about the cost of patented drugs in Canada: 2018 Edition.
Read Article -
Consequences of over-regulating the prices of new drugs in Canada
Read Article -
Medical devices spending in Canada 2013-2017
Read Article -
Does Canada need a Patented Medicine Prices Review Board?
Read Article -
Societal cost savings from abuse deterrent formulations for prescription opioids in Canada
Read Article